Kristen Dahlgren of the Cancer Vaccine Coalition spoke with CURE about why she remains hopeful for the future or cancer ...

In an interview, Dr. Rosario Ligresti highlighted what patients with gastrointestinal stromal tumors, or GIST, should know ...

The GIST treatment landscape has shifted in recent years due to the emergence of new therapies, many of which patients should ...

The FDA declined approval of Darzalex Faspro for newly diagnosed, transplant-ineligible multiple myeloma in its current form.

CURE spoke with an expert about the needs of children in families living with cancer during back-to-school season.

A structured nurse-led clinic can help patients with myeloproliferative neoplasms receive timely support, as well as bridge gaps in symptom reporting.

I share how my daughter’s cancer team let me stay involved and supported, helping me remain present as her mom through every step of treatment.

The FDA approved the Dako Omnis panel to identify patients with colorectal cancer with mismatch repair deficiency.

Being diagnosed with a disease like prostate cancer is a very impactful life event, making it vital to have people you love ...

Through cancer treatment, loss, as well as many life changes, I found healing in simple moments of community and laughter ...

CAR-T cell therapies are now being explored for the treatment of solid tumors like gliomas, Dr. Tanja A. Gruber explained in ...

The FDA granted breakthrough therapy designation to Ifinatamab deruxtecan for some with extensive-stage small cell lung ...